1. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases
- Author
-
Kirtesh R. Patel, Justin Roper, Ian R. Crocker, Jaymin Jhaveri, Anees Dhabaan, Hui-Kuo Shu, Robert H. Press, Eric Elder, Matthew J. Ferris, Bree R. Eaton, Jeffrey M. Switchenko, Mudit Chowdhary, Walter J. Curran, Xinyan Zhang, Tiffany M. Morgan, and Jeffrey J. Olson
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Planning target volume ,Kaplan-Meier Estimate ,Radiosurgery ,Patient Care Planning ,Article ,030218 nuclear medicine & medical imaging ,Cohort Studies ,Lesion ,Necrosis ,03 medical and health sciences ,0302 clinical medicine ,Margin (machine learning) ,medicine ,Humans ,Cumulative incidence ,Radiation Injuries ,Craniotomy ,Survival analysis ,Aged ,Retrospective Studies ,Aged, 80 and over ,Brain Neoplasms ,business.industry ,Margins of Excision ,Retrospective cohort study ,General Medicine ,Middle Aged ,Survival Analysis ,Treatment Outcome ,030220 oncology & carcinogenesis ,Female ,Radiology ,Neoplasm Recurrence, Local ,medicine.symptom ,business ,Follow-Up Studies - Abstract
OBJECTIVEThe optimal margin size in postoperative stereotactic radiosurgery (SRS) for brain metastases is unknown. Herein, the authors investigated the effect of SRS planning target volume (PTV) margin on local recurrence and symptomatic radiation necrosis postoperatively.METHODSRecords of patients who received postoperative LINAC-based SRS for brain metastases between 2006 and 2016 were reviewed and stratified based on PTV margin size (1.0 or > 1.0 mm). Patients were treated using frameless and framed SRS techniques, and both single-fraction and hypofractionated dosing were used based on lesion size. Kaplan-Meier and cumulative incidence models were used to estimate survival and intracranial outcomes, respectively. Multivariate analyses were also performed.RESULTSA total of 133 patients with 139 cavities were identified; 36 patients (27.1%) and 35 lesions (25.2%) were in the 1.0-mm group, and 97 patients (72.9%) and 104 lesions (74.8%) were in the > 1.0–mm group. Patient characteristics were balanced, except the 1.0-mm cohort had a better Eastern Cooperative Group Performance Status (grade 0: 36.1% vs 19.6%), higher mean number of brain metastases (1.75 vs 1.31), lower prescription isodose line (80% vs 95%), and lower median single fraction–equivalent dose (15.0 vs 17.5 Gy) (all p < 0.05). The median survival and follow-up for all patients were 15.6 months and 17.7 months, respectively. No significant difference in local recurrence was noted between the cohorts. An increased 1-year rate of symptomatic radionecrosis was seen in the larger margin group (20.9% vs 6.0%, p = 0.028). On multivariate analyses, margin size > 1.0 mm was associated with an increased risk for symptomatic radionecrosis (HR 3.07, 95% CI 1.13–8.34; p = 0.028), while multifraction SRS emerged as a protective factor for symptomatic radionecrosis (HR 0.13, 95% CI 0.02–0.76; p = 0.023).CONCLUSIONSExpanding the PTV margin beyond 1.0 mm is not associated with improved local recurrence but appears to increase the risk of symptomatic radionecrosis after postoperative SRS.
- Published
- 2019
- Full Text
- View/download PDF